https://www.selleckchem.com/pr....oducts/cilofexor-gs-
re is suggested. To examine the prevalence and predictors of patient-reported barriers to care among survivors of head and neck squamous cell carcinoma and the association with health-related quality of life (HRQOL) outcomes. Retrospective cohort study. Outpatient oncology clinic at an academic tertiary care center. Data were obtained from the UNC Health Registry/Cancer Survivorship Cohort. Barriers to care included self-reported delays in care and inability to obtain needed care due to cost. HRQOL was measured with validated
Like
Comment
Share
